- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03460132
Biological Effects of Commercial Orthodontic Miniscrews
The Biological Effects of Commercial Orthodontic Miniscrews on the Oral Investing Tissue
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The use of miniscrew implants as an anchorage device in orthodontics has gained a widespread acceptance in recent years. There prevailed use has been attributed to its ease in insertion and removal at a relatively low cost with no need to wait for a long time between miniscrew insertion and force application. In this regard; clinical studies have suggested that miniscrew implants may provide stable anchorage during the orthodontic treatment without requiring patient cooperation. These studies proved many successful applications in orthodontics involving; retraction of anterior teeth, correction of open bites, distalization, mesialization, and intrusion of teeth.
In dentistry, various materials are used in implant systems. The implant material must be nontoxic, biocompatible, mechanically sufficient, and having high tension and corrosion resistance. Commercially pure titanium (cp Ti) is the most used material in prosthetic implants because of its; high biocompatibility, high corrosion resistance in body fluids, not allergic, high specific strength, and low elastic modulus when compared with other metallic biomaterials.
On the other hand, orthodontic miniscrew implants are smaller than conventional prosthetic implants and should resist high orthodontic loads. These factors contribute to the possible fracture of cp Ti miniscrew implants during placement, use, and removal. To avoid such fracture, Ti alloy implants, composed with aluminum (6Al) and vanadium (4V), (Ti-6Al-4V), for adding strength and fatigue resistance than cp Ti, are required. Unfortunately, this alloy has a low corrosion resistance and can result in corrosion of the orthodontic miniscrew implants in body fluids.
Any metal or alloy implanted in the human body is a potential source of toxicity. In an oral envelope, miniscrew implants are exposed to a number of potentially destructive physical and chemical agents. Evaluation the potential of conventional dental implants to release metallic ions into the body have been done. However, little attention has been given to metallic ion released from orthodontic miniscrew implant systems and the potential toxicity of these released metal on oral tissues. The concern about this has been limited to orthodontic brackets and wires.
One of the studies concerned with the biocompatibility of different metals used in vivo of different fixed orthodontic appliances and evaluating the presence of metal ions in oral mucosa cells, their potential cytotoxicity, and genotoxic effects. This study concluded that nickel and cobalt metals released from fixed orthodontic appliances could induce DNA damage in oral mucosa cells.
Literature review in this topic listed an expanding area of articles dealing with orthodontic miniscrews. The in vivo studies of cytotoxic effect of metal ions released from orthodontic miniscrew implants in body fluids are limited compared to in vitro studies.
In view of the above review of literature, it will be of great value in clinical orthodontics to investigate the biological effect of commercial orthodontic miniscrew implants on the oral investing tissue.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ahmed Shehata M. Ammar, PhD
- Phone Number: +2 01008180248
- Email: ahmed.sh.amar@azhar.edu.eg
Study Contact Backup
- Name: khaled M. Taha, Master
- Phone Number: +2 01094556203
- Email: kh.taha@azhar.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
The patients will be included in this study if they have the following:
- All cases indicated for bilateral extraction of maxillary first premolar and retraction of canine into the extraction space.
- Age range from 14 to 18 years.
- Full set of permanent teeth (the third molars are not considered).
- No previous orthodontic or orthognathic surgery treatment.
- Good oral and general health.
- All teeth should be caries-free.
- All teeth should be free from any metallic restorations.
Exclusion Criteria:
The patients will be excluded from the study if they have the following:
- History of serious medical problems or taking systemic medication which could affect orthodontic treatment.
- History of serious dental problems (endodontic treatment, apicectomy, or any other dental problems) which could affect orthodontic treatment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Extraction cases
patients receive Tomas orthodontic miniscrew implant as a mean of anchorage augmentation
|
self drilling, bone inserted, screw like device used for anchorage preparation during orthodontic treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
cytotoxicity of orthodontic miniscrew implant
Time Frame: 4 months after initiation of the orthodontic canine retraction
|
Time dependent change in the percentage (%) of dead cells in series of swab samples harvested from area around orthodontic miniscrew implant.
|
4 months after initiation of the orthodontic canine retraction
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Metal release of orthodontic miniscrew implant
Time Frame: 4 months after initiation of the orthodontic canine retraction
|
Time dependent change in the amount (micro-grams, µg) of titanium, aluminum and vanadium traces in series of saliva samples using inductively coupled plasma optical emission spectrometry.
|
4 months after initiation of the orthodontic canine retraction
|
surface changes of orthodontic miniscrew implants
Time Frame: 4 months after initiation of the orthodontic canine retraction
|
surface analysis of orthodontic miniscrew implant (mass percentage) by X-ray fluorescence
|
4 months after initiation of the orthodontic canine retraction
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Al-Azhar 201
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cytotoxicity
-
European Institute of OncologyRecruiting
-
Misr International UniversityNot yet recruitingPlaque, Dental | Cytotoxicity | Antimicrobial | Mouthwash
-
Umeå UniversityUnknownPulmonary Inflammation | CytotoxicitySweden
-
University of AarhusMartin TolstrupEnrolling by invitationHealthy | Cytotoxicity | Yellow Fever Vaccination ReactionDenmark
Clinical Trials on Tomas® Anchorage System - DENTAURUM
-
Ammar AlubaydiCompleted
-
CVRx, Inc.Completed
-
Prof. Dr. Carsten PerkaJulius Wolff InstituteUnknown
-
CereVasc IncAlvaMed, Inc.; Simplified Clinical Data Systems, LLC; Bioscience Consulting,...TerminatedPilot Study to Evaluate the CereVasc® eShunt® System in the Treatment of Communicating HydrocephalusHydrocephalus | Hydrocephalus, CommunicatingUnited States
-
VA Greater Los Angeles Healthcare SystemUniversity of California, Los AngelesRecruitingPost-Traumatic Stress DisorderUnited States
-
Global Kinetics CorporationRecruitingParkinson Disease | Movement DisordersUnited States
-
University of ZurichUniversity of Oxford; University of Padova; University Hospital, Zürich; Swiss... and other collaboratorsCompleted
-
Global Kinetics CorporationWithdrawn